These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 28424536)

  • 1. Rifapentine-linezolid-loaded PLGA microspheres for interventional therapy of cavitary pulmonary tuberculosis: preparation and in vitro characterization.
    Huang J; Chen Z; Li Y; Li L; Zhang G
    Drug Des Devel Ther; 2017; 11():585-592. PubMed ID: 28424536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and in vitro characterization of drug delivery system of rifapentine for osteoarticular tuberculosis.
    Wu J; Zuo Y; Hu Y; Wang J; Li J; Qiao B; Jiang D
    Drug Des Devel Ther; 2015; 9():1359-66. PubMed ID: 25834394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Staphylococcus aureus-induced chronic osteomyelitis with bone-like hydroxyapatite/poly amino acid loaded with rifapentine microspheres.
    Yan L; Jiang DM; Cao ZD; Wu J; Wang X; Wang ZL; Li YJ; Yi YF
    Drug Des Devel Ther; 2015; 9():3665-76. PubMed ID: 26213463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and in vitro evaluation of etoposide-loaded PLGA microspheres for pulmonary drug delivery.
    Feng R; Zhang Z; Li Z; Huang G
    Drug Deliv; 2014 May; 21(3):185-92. PubMed ID: 24107001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rifapentine-loaded PLGA microparticles for tuberculosis inhaled therapy: Preparation and in vitro aerosol characterization.
    Parumasivam T; Leung SS; Quan DH; Triccas JA; Britton WJ; Chan HK
    Eur J Pharm Sci; 2016 Jun; 88():1-11. PubMed ID: 27049049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of formulation parameters on encapsulation efficiency and release behavior of thienorphine loaded PLGA microspheres.
    Yang Y; Gao Y; Mei X
    Pharm Dev Technol; 2013; 18(5):1169-74. PubMed ID: 21967467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and characterization of rifampicin-PLGA microspheres/sodium alginate in situ gel combination delivery system.
    Hu C; Feng H; Zhu C
    Colloids Surf B Biointerfaces; 2012 Jun; 95():162-9. PubMed ID: 22424828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(D,L-lactic-co-glycolic acid) microspheres using a double emulsion/solvent evaporation technique.
    Karal-Yılmaz O; Serhatlı M; Baysal K; Baysal BM
    J Microencapsul; 2011; 28(1):46-54. PubMed ID: 21171816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
    Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
    Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of NaCl in outer water phase on the characteristics of BSA-loaded PLGA sustained-release microspheres fabricated by a solid-in-oil-in-water emulsion technique].
    Zhou XL; He JT; Zhou ZT; Ma SF; Jiang Y; Wang Y
    Yao Xue Xue Bao; 2010 Aug; 45(8):1057-63. PubMed ID: 21351596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-methasone-containing biodegradable poly(lactide-co-glycolide) acid microspheres for intraarticular injection: effect of formulation parameters on characteristics and in vitro release.
    Song X; Song SK; Zhao P; Wei LM; Jiao HS
    Pharm Dev Technol; 2013; 18(5):1220-9. PubMed ID: 22295954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of insulin during the erosion of poly(lactic acid) and poly(lactic-co-glycolic acid) microspheres.
    Ibrahim MA; Ismail A; Fetouh MI; Göpferich A
    J Control Release; 2005 Sep; 106(3):241-52. PubMed ID: 15970349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers.
    Jackson JK; Hung T; Letchford K; Burt HM
    Int J Pharm; 2007 Sep; 342(1-2):6-17. PubMed ID: 17555895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of andrographolide loaded PLGA microspheres: optimization, characterization and in vitro-in vivo correlation.
    Jiang Y; Wang F; Xu H; Liu H; Meng Q; Liu W
    Int J Pharm; 2014 Nov; 475(1-2):475-84. PubMed ID: 25219858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of dual delivery antituberculotic system containing rifapentine microspheres and adipose stem cells seeded in hydroxyapatite/tricalcium phosphate.
    Liang Q; Song X; She S; Wang Z; Wang C; Jiang D
    Drug Des Devel Ther; 2019; 13():373-384. PubMed ID: 30705585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and characterization of negatively charged poly(lactic-co-glycolic acid) microspheres.
    Xu Q; Crossley A; Czernuszka J
    J Pharm Sci; 2009 Jul; 98(7):2377-89. PubMed ID: 19009589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fabrication and characterization of monodisperse PLGA-alginate core-shell microspheres with monodisperse size and homogeneous shells for controlled drug release.
    Wu J; Kong T; Yeung KW; Shum HC; Cheung KM; Wang L; To MK
    Acta Biomater; 2013 Jul; 9(7):7410-9. PubMed ID: 23535235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation, characterization, and in vitro evaluation of physostigmine-loaded poly(ortho ester) and poly(ortho ester)/poly(D,L-lactide-co-glycolide) blend microspheres fabricated by spray drying.
    Wang L; Chaw CS; Yang YY; Moochhala SM; Zhao B; Ng S; Heller J
    Biomaterials; 2004 Jul; 25(16):3275-82. PubMed ID: 14980422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characteristics of interferon-alpha poly(lactic-co-glycolic acid) microspheres.
    Yang F; Song FL; Pan YF; Wang ZY; Yang YQ; Zhao YM; Liang SZ; Zhang YM
    J Microencapsul; 2010; 27(2):133-41. PubMed ID: 20121486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mesoporous silicon/poly-(DL-lactic-co-glycolic) acid microsphere for long time anti-tuberculosis drug delivery.
    Xu W; Wei X; Wei K; Cao X; Zhong S
    Int J Pharm; 2014 Dec; 476(1-2):116-23. PubMed ID: 25271077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.